Biomek® FX
High- Quality Plasmid Purification Using Promega's Wizard* MagneSil*
Plasmid Purification System and the Biomek® FX Liquid
Handling System
Monique Coles**, Graham Threadgill, Ph.D***. and Laura Pajak, Ph.D.**
Beckman Coulter, Inc.
**Indianapolis, Indiana and ***Fullerton, California
Don Smith
Promega Corporation - www.promega.com
Madison, Wisconsin
Method: BFXMagPlasmid2pl.exe (75 KB)
Plasmid Purification using the Biomek® FX with a Magnabot* 96 Separation Device and Promega's Wizard* Magnesil* Plasmid Purification System.
**Indianapolis, Indiana and ***Fullerton, California**Don Smith
Promega Corporation - www.promega.com
Madison, Wisconsin
Method: MagPlasmid with Magnabot.exe (104 KB)
Biomek FX system configuration for both methods:
- Biomek FX software version 2.0 to 2.5
- Hybrid System Multichannel/Span 8
- Can be run on any Biomek FX System Configuration which has a multichannel
pod
as the left Bridge
To install either the MagneSil Plasmid Purification method or the MagneSil Plasmid Purification with a Magnabot method on the Biomek FX:
- Download the self-extracting file containing the method and import file.
- Double click the file to extract.
- Chose a directory to copy the files.
- Open the Biomek FX software.
- Under the File menu chose Open.
- Select the plasmid purification method.
- If labware definitions are needed follow the additional steps below:
- In the Biomek FX software under the Tools menu choose Import/Export Utility.
- Select Open.
- Select the directory where the import file (.imp) is located and choose Open.
- Open the Labware folder by clicking the + next to it on the Import File side.
- Drag and drop the desired setting(s) to the Current Workspace side of the Import/Export Utility. (Note: Dragging an entire folder will copy all of the settings in that folder. You will then have the opportunity of overwriting or not overwriting each individual setting.)
- Continue to import settings using step 4 until all desired settings are imported.
* All trademarks are the property of their respective owners. Where applicable, the PCR process is covered by patents owned by Roche Molecular Systems, Inc., and F. Hoffman-LaRoche, Ltd.
